155 related articles for article (PubMed ID: 35611997)
1. Population pharmacokinetic model for once-daily intravenous busulfan in pediatric subjects describing time-associated clearance.
Lawson R; Staatz CE; Fraser CJ; Ramachandran S; Teague L; Mitchell R; O'Brien T; Hennig S
CPT Pharmacometrics Syst Pharmacol; 2022 Aug; 11(8):1002-1017. PubMed ID: 35611997
[TBL] [Abstract][Full Text] [Related]
2. Test Dose Pharmacokinetics in Pediatric Patients Receiving Once-Daily IV Busulfan Conditioning for Hematopoietic Stem Cell Transplant: A Reliable Approach?
Brooks KM; Jarosinski P; Hughes T; Kang E; Shah NN; Gall JBL; Hickstein DD; De Ravin SS; George JM; Kumar P
J Clin Pharmacol; 2018 Mar; 58(3):332-339. PubMed ID: 29238995
[TBL] [Abstract][Full Text] [Related]
3. Utilization of a Population Pharmacokinetic Model to Improve a Busulfan Test-Dose Strategy in Allogeneic Hematopoietic Cell Transplant Recipients.
Dunlap TC; Weiner DL; Kemper RM; Kardouh M; DeVane SC; Symonds A; Shaw JR; Armistead PM; Ptachcinski JR; Crona DJ
J Clin Pharmacol; 2023 Sep; 63(9):1026-1035. PubMed ID: 37122163
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics of oral busulfan in children.
Schiltmeyer B; Klingebiel T; Schwab M; Mürdter TE; Ritter CA; Jenke A; Ehninger G; Gruhn B; Würthwein G; Boos J; Hempel G
Cancer Chemother Pharmacol; 2003 Sep; 52(3):209-16. PubMed ID: 12811512
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics of busulfan in children: increased evidence for body surface area and allometric body weight dosing of busulfan in children.
Trame MN; Bergstrand M; Karlsson MO; Boos J; Hempel G
Clin Cancer Res; 2011 Nov; 17(21):6867-77. PubMed ID: 21918171
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetic analysis of intravenous busulfan: GSTA1 genotype is not a predictive factor of initial dose in Chinese adult patients undergoing hematopoietic stem cell transplantation.
Sun Y; Huang J; Hao C; Li Z; Liang W; Zhang W; Chen B; Yang W; Hu J
Cancer Chemother Pharmacol; 2020 Feb; 85(2):293-308. PubMed ID: 31834435
[TBL] [Abstract][Full Text] [Related]
7. Review of the Pharmacokinetics and Pharmacodynamics of Intravenous Busulfan in Paediatric Patients.
Lawson R; Staatz CE; Fraser CJ; Hennig S
Clin Pharmacokinet; 2021 Jan; 60(1):17-51. PubMed ID: 33128207
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetic-based dosing of intravenous busulfan in pediatric patients.
Booth BP; Rahman A; Dagher R; Griebel D; Lennon S; Fuller D; Sahajwalla C; Mehta M; Gobburu JV
J Clin Pharmacol; 2007 Jan; 47(1):101-11. PubMed ID: 17192508
[TBL] [Abstract][Full Text] [Related]
9. The Correlation Between Busulfan Exposure and Clinical Outcomes in Chinese Pediatric Patients: A Population Pharmacokinetic Study.
Du X; Huang C; Xue L; Jiao Z; Zhu M; Li J; Lu J; Xiao P; Zhou X; Mao C; Zhu Z; Dong J; Liu X; Chen Z; Zhang S; Ding Y; Hu S; Miao L
Front Pharmacol; 2022; 13():905879. PubMed ID: 35784763
[No Abstract] [Full Text] [Related]
10. Population pharmacokinetics of intravenous busulfan in patients undergoing hematopoietic stem cell transplantation.
Takama H; Tanaka H; Nakashima D; Ueda R; Takaue Y
Bone Marrow Transplant; 2006 Feb; 37(4):345-51. PubMed ID: 16400337
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of treosulfan cumulative exposure in paediatric patients through population pharmacokinetics and dosing simulations.
Rosser SPA; Lee S; Kohli S; Keogh SJ; Chung J; O'Brien T; Fraser C; McLachlan AJ; Shaw PJ; Nath CE
Br J Clin Pharmacol; 2023 Apr; 89(4):1413-1424. PubMed ID: 36369677
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of two software using Bayesian methods for monitoring exposure and dosing once-daily intravenous busulfan in paediatric patients receiving haematopoietic stem cell transplantation.
Lawson R; Paterson L; Fraser CJ; Hennig S
Cancer Chemother Pharmacol; 2021 Sep; 88(3):379-391. PubMed ID: 34021809
[TBL] [Abstract][Full Text] [Related]
13. Busulfan in infant to adult hematopoietic cell transplant recipients: a population pharmacokinetic model for initial and Bayesian dose personalization.
McCune JS; Bemer MJ; Barrett JS; Scott Baker K; Gamis AS; Holford NH
Clin Cancer Res; 2014 Feb; 20(3):754-63. PubMed ID: 24218510
[TBL] [Abstract][Full Text] [Related]
14. A simple dosing scheme for intravenous busulfan based on retrospective population pharmacokinetic analysis in korean patients.
Choe S; Kim G; Lim HS; Cho SH; Ghim JL; Jung JA; Kim UJ; Noh G; Bae KS; Lee D
Korean J Physiol Pharmacol; 2012 Aug; 16(4):273-80. PubMed ID: 22915993
[TBL] [Abstract][Full Text] [Related]
15. Thirteen years' experience of pharmacokinetic monitoring and dosing of busulfan: can the strategy be improved?
Buffery PJ; Allen KM; Chin PK; Moore GA; Barclay ML; Begg EJ
Ther Drug Monit; 2014 Feb; 36(1):86-92. PubMed ID: 24299921
[TBL] [Abstract][Full Text] [Related]
16. Pediatric patients undergoing hematopoietic stem cell transplantation can greatly benefit from a novel once-daily intravenous busulfan dosing nomogram.
Rhee SJ; Lee JW; Yu KS; Hong KT; Choi JY; Hong CR; Park KD; Shin HY; Song SH; Kang HJ; Lee H
Am J Hematol; 2017 Jul; 92(7):607-613. PubMed ID: 28370238
[TBL] [Abstract][Full Text] [Related]
17. Population Pharmacokinetic Model of Intravenous Busulfan in Hematopoietic Cell Transplantation: Systematic Review and Comparative Simulations.
Takahashi T; Jaber MM; Brown SJ; Al-Kofahi M
Clin Pharmacokinet; 2023 Jul; 62(7):955-968. PubMed ID: 37415003
[TBL] [Abstract][Full Text] [Related]
18. Body weight-dependent pharmacokinetics of busulfan in paediatric haematopoietic stem cell transplantation patients: towards individualized dosing.
Bartelink IH; Boelens JJ; Bredius RG; Egberts AC; Wang C; Bierings MB; Shaw PJ; Nath CE; Hempel G; Zwaveling J; Danhof M; Knibbe CA
Clin Pharmacokinet; 2012 May; 51(5):331-45. PubMed ID: 22455797
[TBL] [Abstract][Full Text] [Related]
19. Precision dosing of intravenous busulfan in pediatric hematopoietic stem cell transplantation: Results from a multicenter population pharmacokinetic study.
Ben Hassine K; Nava T; Théoret Y; Nath CE; Daali Y; Kassir N; Lewis V; Bredius RGM; Shaw PJ; Bittencourt H; Krajinovic M; Uppugunduri CRS; Ansari M
CPT Pharmacometrics Syst Pharmacol; 2021 Sep; 10(9):1043-1056. PubMed ID: 34453497
[TBL] [Abstract][Full Text] [Related]
20. Intra-individual Pharmacokinetic Variability of Intravenous Busulfan in Hematopoietic Stem Cell-Transplanted Children.
Marsit H; Philippe M; Neely M; Rushing T; Bertrand Y; Ducher M; Leclerc V; Guitton J; Bleyzac N; Goutelle S
Clin Pharmacokinet; 2020 Aug; 59(8):1049-1061. PubMed ID: 32157629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]